Advisor Group Holdings, Inc. Synthetic Biologics, Inc. Transaction History

Advisor Group Holdings, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$2.9 - $4.6 $414 - $657	-143 Reduced 22.99%	479 $0
Q3 2020 Nov 12, 2020	BUY	$4.5 - $7.1 $261 - $411	58 Added 10.28%	622 $0
Q1 2020 May 18, 2020	BUY	$2.7 - $6.1 $1,522 - $3,440	564 New	564 $0

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.